Fibromyalgia Treatments Market 2018 - Geographical Analysis up to 2023 with Topmost Vendors are Astellas Pharma, Johnson & Johnson Services, SANOFI,etc.

Universal Fibromyalgia Treatments Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Fibromyalgia Treatments market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023.

Market Scenario:

Fibromyalgia is a condition that causes lasting and debilitating muscle pain and fatigue. In the recent years, cases of road traffic injuries have been rising at an alarming rate, which further leads to the rising prevalence of fibromyalgia as road traffic accidents are likely to develop widespread chronic pain. Psychiatric disorders are increasingly prevalent in case of fibromyalgia, and post-traumatic stress disorders are also seen with the increasing occurrence rate. Screening for post-traumatic stress disorder symptoms is also an essential part of the assessment process in patients suffering from fibromyalgia.

Avail Sample copy @ https://www.marketresearchfuture.com/sample_request/1879 .

It is noted that the rising occurrences of traumatic stress and road accidents is the key factor driving the fibromyalgia treatment market. According to a study published in the Pain Research and Management Journal, in 2014, it was found that physical trauma is followed by the fibromyalgia syndrome. In the study, conducted with a specific cohort of individuals involved in motor vehicle collisions, it was found that 8% of individuals developed widespread chronic pain. Fibromyalgia is characterized by widespread chronic pain. The study has also demonstrated the incidence rate of fibromyalgia in the survivors of a train crash in Israel which was 15%.

Other factors, such as increasing cases of rheumatic diseases, growing awareness among the population, rising geriatric population, unmet medical needs in the fibromyalgia treatment, and rising popularity of Chinese treatment options are also promoting the growth of the market. Fibromyalgia is considered as a confounding factor for the diagnosis and the assessment of the rheumatic disease activity.

Despite these drivers, there are some issues associated with the fibromyalgia treatment market. Lack of infrastructure in middle- and low-income countries and difficult diagnosis may hamper the growth of the market. Irritable Bowel Syndrome (IBS) is also found to be highly associated with fibromyalgia. According to the study published in the Medicine Journal in 2015, fibromyalgia was associated with a 1.54-fold increased risk for the irritable bowel syndrome. In Taiwan, the incidence rate of IBS is found to be around 10 to 20%, whereas the incidence rate of fibromyalgia in Taiwan's general population is around 2 to 4%.

It is estimated that the Fibromyalgia Treatment Market Is Expected To Grow at a CAGR Of 17.5% During The Forecast Period Of 2017 To 2023.

Top Vendors of Fibromyalgia Treatments Market Research Report:                                                     

Pfizer, GlaxoSmithKline, AstraZeneca, F. Hoffmann-La Roche AG, Astellas Pharma, Johnson & Johnson Services, Inc., SANOFI, Eli Lilly and Company, Bayer AG, ALLERGAN, Boehringer Ingelheim, AbbVie, Cephalon, Inc., Sunovion Pharms Inc, Jazz Pharmaceuticals, Vertical Pharmaceuticals, ABBOTT, NOVARTIS, and others.

Segmentation:

The fibromyalgia treatment market is segmented on the basis of treatment, diagnosis, and end-user.
On the basis of treatment, the market is segmented into symptomatic treatment and targeted treatment.
On the basis of diagnosis, the market is classified into laboratory evaluation and presence of central sensitization.
On the basis of end-user, the market is segmented into hospitals, clinics, diagnostic centers, and others.
New Trends/Advancements:

‘Avacen Medical,’ of late, was rewarded for developing a dry heating instrument for a kind of pain that is widely found in fibromyalgia. The global consulting firm, ‘Frost and Sullivan’ felicitated ‘Avacen’ with an innovation award for making ‘Avacen 100.’ The consultant, based in Mountain View at California, designed the award post the thorough analysis of European fibromyalgia devices.

Get Discount @ https://www.marketresearchfuture.com/check-discount/1879 .

Regional Analysis:

The Americas dominates the fibromyalgia treatment market owing to the rising awareness among people, rising cases of chronic rheumatic diseases, and increasing healthcare expenditure. As per the 2017 statistics suggested by the Centers for Disease Control and Prevention (CDC), around 54.4 million adults in the United States have arthritis, which is about 25% of the population. It is also reported that by 2040, nearly 78 million adults, aged 18 years or older, are projected to have arthritis in the United States.

Europe holds the second position in the fibromyalgia treatment market. It is expected that the financial support provided by governments and private bodies for research and development and amendments in reimbursement policies in healthcare will drive the fibromyalgia treatment market in Europe.

Asia Pacific is the fastest growing market for fibromyalgia treatments, owing to a huge patient pool and rising healthcare expenditure in some countries within this region. In 2014, the total expenditure on healthcare per capita was USD 731 in China, suggested by the World Health Organization (WHO). According to the BMC Health Services Research Journal, China’s healthcare expenditure grew at a rate of 11.6% per year. The rate is much faster than the growth of the country’s economy, i.e., 9.9% per year.

The Middle East and Africa has the lowest market for fibromyalgia treatments due to lack of technical knowledge and poor medical facilities.

Table of Content:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

…TOC CONTINUED

List of Tables:

Table 1 Fibromyalgia Treatment Industry Synopsis, 2017–2023

Table 2 Fibromyalgia Treatment Market Estimates And Forecast, 2017–2023, (USD Million)

Table 3 Fibromyalgia Treatment Market, By Region, 2017–2023, (USD Million)

Table 4 Fibromyalgia Treatment Market, By Diagnosis, 2017–2023, (USD Million)

Table 5 Fibromyalgia Treatment Market, By Treatment, 2017–2023, (USD Million)

Table 6 Fibromyalgia Treatment Market, By End-User, 2017–2023, (USD Million)

Table 7 North America Fibromyalgia Treatment Market, By Diagnosis, 2017–2023, (USD Million)

Table 8 North America Fibromyalgia Treatment Market, By Treatment, 2017–2023, (USD Million)

Table 9 North America Fibromyalgia Treatment Market, By End-User, 2017–2023, (USD Million)

Table 10 US Fibromyalgia Treatment Market, By Diagnosis, 2017–2023, (USD Million)

Customization on this Report, Ask to Expertise @ https://www.marketresearchfuture.com/enquiry/1879 .

…CONTINUED

List of Figures:

Figure 1 Research Process

Figure 2 Segmentation For Fibromyalgia Treatment Market

Figure 3 Segmentation Market Dynamics For Fibromyalgia Treatment Market

Figure 4 Global Fibromyalgia Treatment Market Share, By Diagnosis, 2016

Figure 5 Global Fibromyalgia Treatment Market Share, By Treatment, 2016

Figure 6 Global Fibromyalgia Treatment Market Share, By End-User, 2016

Figure 7 Global Fibromyalgia Treatment Market Share, By Region, 2016

Figure 8 North America Fibromyalgia Treatment Market Share, By Country, 2016

Figure 9 Europe Fibromyalgia Treatment Market Share, By Country, 2016

Figure 10 Asia Pacific Fibromyalgia Treatment Market Share, By Country, 2016

…CONTINUED

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.